International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M.D., ATSUMI, T., BRANCH, D.W., BREY, R.L., CERVERA, R., DERKSEN, R.H.W.M., DE GROOT, P.G. +7 more·2006·Journal of Thrombosis and Haemostasis

Cited by (1,054)

Items 901–1,000 of 1,054

  1. Is Obstetric Antiphospholipid Syndrome a Primary Nonthrombotic, Proinflammatory, Complement-Mediated Disorder Related to Antiphospholipid Antibodies?
    Jaume Alijotas‐Reig, Miquel Vilardell · 2009 · Obstetrical & Gynecological Survey
  2. Current and future management of pediatric venous thromboembolism
    Bryce A. Kerlin · 2012 · American Journal of Hematology
  3. Paternal and maternal carriage of the annexin A5 M2 haplotype are equal risk factors for recurrent pregnancy loss: a pilot study
    Nina Rogenhofer, Laura Engels, Nadja Bogdanova, Frank Tüttelmann, Arseni Markoff, Christian Thaler · 2012 · Fertility and Sterility
  4. Thrombosis in women: what are the knowledge gaps in 2013?
    Saskia Middeldorp · 2013 · Journal of Thrombosis and Haemostasis
  5. Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy
    Antoine Malek · 2013 · Expert Review of Clinical Immunology
  6. Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome
    José Antonio Vargas‐Hitos, Oier Ateka–Barrutia, Shirish R Sangle, Munther A. Khamashta · 2011 · Annals of the Rheumatic Diseases
  7. Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients
    Fabio Cacciapaglia, Enrico Maria Zardi, G. Coppolino, Francesca Buzzulini, Domenico Paolo Emanuele Margiotta, Luisa Arcarese, Marta Vadacca, Antonio Amoroso, Antonella Afeltra · 2009 · Lupus
  8. Obstetric and vascular APS: Same autoantibodies but different diseases?
    Pier Luigi Meroni, Elena Raschi, Claudia Grossi, Francesca Pregnolato, Laura Trespìdi, Barbara Acaia, María Orietta Borghi · 2012 · Lupus
  9. Anticardiolipin Antibodies in HIV Infection Are Independently Associated with Antibodies to the Membrane Proximal External Region of gp41 and with Cell‐Associated HIV DNA and Immune Activation
    Valérie Martinez, Marie‐Claude Diemert, Martine Braibant, Valérie Potard, J.L. Charuel, Françis Barin, Dominique G. Costagliola, Éric Caumes, Jean‐Pierre Clauvel, Brigitte Autran et al. · 2008 · Clinical Infectious Diseases
  10. Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview
    Dana H.F. Quaden, Liesbeth M. De Winter, Veerle A Somers · 2016 · Autoimmunity Reviews
  11. The Lupus Anticoagulant Paradox
    Jessica E. Molhoek, Philip G. de Groot, Rolf T. Urbanus · 2017 · Seminars in Thrombosis and Hemostasis
  12. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies
    Micaela Fredi, Laura Andréoli, E. Aggogeri, Elisa Bettiga, Maria Grazia Lazzaroni, Véronique Le Guern, Andrea Lojacono, Nathalie Morel, Jean Charles Piette, Sonia Zatti et al. · 2018 · Frontiers in Immunology
  13. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies
    Maria Grazia Lazzaroni, Micaela Fredi, Laura Andréoli, Cecilia Beatrice Chighizola, Teresa Del Ross, Maria Gerosa, Anna Kuzenko, Maria-Gabriella Raimondo, Andrea Lojacono, Francesca Ramazzotto et al. · 2019 · Frontiers in Immunology
  14. Prevalence of confirmed antiphospholipid syndrome in 18‐50 years unselected patients with first unprovoked venous thromboembolism
    Sébastien Miranda, Junghyun Park, Grégoire Le Gal, Siavash Piran, Shemina Kherani, Marc Alan Rodger, Aurélien Delluc · 2019 · Journal of Thrombosis and Haemostasis
  15. Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab
    Cécile Yelnik, Sébastien Miranda, Arsène MEKINIAN, Estibaliz Lazaro, Thomas Quéméneur, François Provôt, Marie Frimat, Sandrine Morell‐Dubois, Véronique Le Guern, Eric HACHULLA et al. · 2020 · Blood
  16. Hemostatic Abnormalities in COVID-19: An Update
    Mukul Aggarwal, Jasmita Dass, Manoranjan Mahapatra · 2020 · Indian Journal of Hematology and Blood Transfusion
  17. An Update on Antiphospholipid Syndrome
    Eleni Xourgia, Maria G. Tektonidou · 2021 · Current Rheumatology Reports
  18. Antiphospholipid antibodies in critically ill patients with cancer: A prospective cohort study
    Juliana Vassalo, Nelson Spector, Ernesto de Meis, Ligia SCF Rabello, Maíra M. Rosolem, Pedro Emmanuel Alvarenga Americano do Brasil, Jorge I. Salluh, Márcio Soares · 2014 · Journal of Critical Care
  19. A critical assessment of the role of antiphospholipid antibodies in infertility
    Karen Buckingham, Larry Chamley · 2009 · Journal of Reproductive Immunology
  20. Annexin A2: biology and relevance to the antiphospholipid syndrome
    Erin Cockrell, RG Espinola, KR McCrae · 2008 · Lupus
  21. The obstetric antiphospholipid syndrome
    Ronald H. W. M. Derksen, Ph.G. de Groot · 2007 · Journal of Reproductive Immunology
  22. Hypercoagulation Testing in Ischemic Stroke
    Aliyah Rahemtullah, Elizabeth M. Van Cott · 2007 · Archives of Pathology & Laboratory Medicine
  23. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus
    Jönsen, A., Clarke, A. E., Joseph, L., Belisle, P., Bernatsky, S., Nived, O., Bengtsson, A. A., Sturfelt, G., Pineau, C. A. · 2011 · Arthritis Care & Research
  24. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: part II–lupus anticoagulant
    Favaloro, Emmanuel, Bonar, Roslyn, Marsden, Katherine · 2012 · Seminars in Thrombosis and Hemostasis
  25. IgM Anti-ß<sub>2</sub>Glycoprotein I Is Protective Against Lupus Nephritis and Renal Damage in Systemic Lupus Erythematosus
    MEHRANI, TARANEH, PETRI, MICHELLE · 2011 · The Journal of Rheumatology
  26. Advances in the Pathophysiology of Thrombosis in Antiphospholipid Syndrome: Molecular Mechanisms and Signaling through Lipid Rafts
    Antonella Capozzi, Valeria Manganelli, Gloria Riitano, Daniela Caissutti, Agostina Longo, Tina Garofalo, Maurizio Sorice, Roberta Misasi · 2023 · Journal of Clinical Medicine
  27. Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE)
    Marwan Fakih, Wael A. Harb, Daruka Mahadevan, Hani M. Babiker, Jordan D. Berlin, Tom Lillie, David Krige, Jo Carter, Chris Cox, Minesh Patel et al. · 2023 · Journal for ImmunoTherapy of Cancer
  28. An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies
    Bas de Laat, Ronald H. W. M. Derksen, Guido Reber, Jacek Musiał, Jakub Swadźba, Borut Božič, Saša Čučnik, Véronique Regnault, Ricardo R Forastiero, Barry John Woodhams et al. · 2010 · Journal of Thrombosis and Haemostasis
  29. A novel pathway of cellular activation mediated by antiphospholipid antibody‐induced extracellular vesicles
    Meifang Wu, John Barnard, Suman Kundu, Keith R. McCrae · 2015 · Journal of Thrombosis and Haemostasis
  30. Comparative incidence of pregnancy outcomes in thrombophilia-positive women from the NOH-APS observational study
    Sylvie Bouvier, Éva Cochery-Nouvellon, Géraldine Lavigne-Lissalde, Éric Mercier, Pascale Fabbro-Péray, Jean-Pierre Balducchi, P. Marès, Jean‐Christophe Gris · 2013 · Blood
  31. The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic
    Christine A. Clark, Judith Davidovits, Karen A. Spitzer, Carl A. Laskin · 2013 · Blood
  32. A Role for Toll-Like Receptor Mediated Signals in Neutrophils in the Pathogenesis of the Anti-Phospholipid Syndrome
    Gerd Gladigau, Philipp Haselmayer, I. Scharrer, Markus Munder, Nadine Prinz, Karl Johannes Lackner, Hansjörg Schild, Pamela Stein, Markus Philipp Radsak · 2012 · PLoS ONE
  33. Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review
    Olga Amengual, Daisuke Fujita, Erika Ota, Loreto Carmona, Kenji Oku, Mayumi Sugiura‐Ogasawara, Atsuko Murashima, Tatsuya Atsumi · 2015 · Lupus
  34. The Antiphospholipid Syndrome
    Jacob H. Rand · 2007 · Hematology
  35. Anti-phosphatidylserine, anti-cardiolipin, anti-β2 glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8–12 gestational weeks
    Mai S. Sater, Ramzi R. Finan, Farah Marwan Abu-Hijleh, Tala M. Abu‐Hijleh, Wassim Youssef Almawi · 2012 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  36. NF‐κB is activated from endosomal compartments in antiphospholipid antibodies‐treated human monocytes
    Karim J. Brandt, Céline Fickentscher, Françoise Boehlen, Egbert K. O. Kruithof, Philippe de Moerloose · 2014 · Journal of Thrombosis and Haemostasis
  37. A Comparison of Lupus Anticoagulant–Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without
    Vittorio Pengo, Alessandra Biasiolo, Paolo Gresele, Francesco Marongiu, Nicoletta Erba, Fabio Veschi, Angelo Ghirarduzzi, Doris Barcellona, Armando Tripodi · 2007 · Arteriosclerosis Thrombosis and Vascular Biology
  38. The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study
    Arsenio Spinillo, Fausta Beneventi, Elena Locatelli, Véronique Laure Ramoni, Roberto Felice Caporali, Claudia Alpini, Giulia Albonico, Chiara Cavagnoli, Carlomaurizio Montecucco · 2016 · BMC Pregnancy and Childbirth
  39. Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay
    Anna Petráčková, Andrea Smržová, Petr Gajdoš, M. Schubertová, Petra Schneiderová, Pavel Krömer, Václav Snåšel, Martina Skácelová, František Mrázek, Josef Zadražil et al. · 2017 · Clinical Proteomics
  40. Everything the clinician needs to know about evidence-based anticoagulation in pregnancy
    Luuk J.J. Scheres, Ingrid M. Bistervels, Saskia Middeldorp · 2018 · Blood Reviews
  41. How we manage Philadelphia‐negative myeloproliferative neoplasms in pregnancy
    Susan E. Robinson, Claire N. Harrison · 2020 · British Journal of Haematology
  42. Clinical and laboratory practice for lupus anticoagulant testing: an International Society of Thrombosis and Haemostasis Scientific and Standardization Committee survey
    Cohen, Hannah, Mackie, Ian J., Devreese, Katrien M.J. · 2019 · Journal of Thrombosis and Haemostasis
  43. High Prevalence of Acquired Thrombophilia Without Prognosis Value in Patients With Coronavirus Disease 2019
    Émile Ferrari, Benjamin Sartre, Fabien Squara, Julie Contenti, Céline Occelli, Fabien Lemoël, J. Levraut, Denis Doyen, Jean Dellamonica, V. Mondain et al. · 2020 · Journal of the American Heart Association
  44. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required
    FAVALORO, E.J., BONAR, R., ZEBELJAN, D., KERSHAW, G., MARSDEN, K. · 2010 · Journal of Thrombosis and Haemostasis
  45. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome
    Henrique Luiz Staub, María Laura Bertolaccini, Munther A. Khamashta · 2012 · Autoimmunity Reviews
  46. Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome
    Noémie Abisror, Arsène MEKINIAN, Eric Lachassinne, Pascale Nicaise‐Roland, Loïc de Pontual, Sylvie Chollet‐Martin, Nathalie Boddaert, Lionel Carbillon, O. Fain · 2013 · Seminars in Arthritis and Rheumatism
  47. Antiphospholipid antibodies — We are not quite there yet
    Rolf T. Urbanus, Philip G. de Groot · 2011 · Blood Reviews
  48. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus
    Ricardo Silvariño, Francesc Sant, Gerard Espinosa, Guillermo Pons‐Estel, Manel Solé, Ricard Cervera, Pilar Arrizabalaga · 2011 · Lupus
  49. Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome
    Michael Mähler, Roger Albesa, Navid Zohoury, María Laura Bertolaccini, Oier Ateka–Barrutia, J L Rodriguez-Garcia, Gary L. Norman, Munther A. Khamashta · 2016 · Lupus
  50. Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
    Savino Sciascia, Simone Baldovino, Karen Ingrid Schreiber, Laura Solfietti, Massimo Radin, María José Cuadrado, Elisa Menegatti, Doruk Erkan, Dario Roccatello · 2016 · Clinical and Molecular Allergy
  51. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus
    Tünde Tarr, Gábor Papp, Nikolett Nagy, Edina Cserép, Margit Zeher · 2016 · Clinical Rheumatology
  52. Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence
    Gabriela Medina, Eduardo Briones-García, María Pilar Cruz-Domínguez, Óscar Iván Florez-Durante, Luis Javier Jara · 2017 · Autoimmunity Reviews
  53. Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study
    Karen J. Gibbins, Anne E. Tebo, Shaelee Nielsen, David Ware Branch · 2018 · Lupus
  54. Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications
    Eleni Xourgia, Maria G. Tektonidou · 2019 · Journal of Autoimmunity
  55. Antiphospholipid Antibody Syndrome and Infertility
    Vivian de Oliveira Rodrigues, Adriana de Góes e Silva Soligo, Gabriel Duque Pannain · 2019 · Revista Brasileira Ginecologia e Obstetrícia
  56. Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses
    Ole Bjarne Christiansen, Henriette Svarre Nielsen, Marie Lund, Rudi Steffensen, Kim Varming · 2008 · Human Reproduction
  57. Evaluating the association between clozapine and venous thromboembolism
    Christopher A. Paciullo · 2008 · American Journal of Health-System Pharmacy
  58. Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data
    Brigitta A. Vcelar, Gabriela M. Stiegler, Hermann Maximilian Wolf, Wolfgang E. Muntean, Bettina Leschnik, Saurabh Mehandru, Martin H. Markowitz, Christine Armbruster, Renate Kunert, Martha Marianne Eibl et al. · 2007 · AIDS
  59. Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients
    Pablo Bartolucci, Sabine Bréchignac, Pascal Cohen, Véronique Le Guern, Loı̈c Guillevin · 2007 · Lupus
  60. Risk Scale for the diagnosis of antiphospholipid syndrome
    Savino Sciascia, Domenico Cosseddu, Barbara Montaruli, Anna Kuzenko, Maria Tiziana Bertero · 2011 · Annals of the Rheumatic Diseases
  61. The effect of unfractionated heparin, enoxaparin and danaparoid on lupus anticoagulant testing. Can activated carbon eliminate false positive results?
    De Kesel, Pieter M.M., Devreese, Katrien M.J. · 2020 · Research and Practice in Thrombosis and Haemostasis
  62. Antibodies to Domain 4/5 (Dm4/5) of β2-Glycoprotein 1 (β2GP1) in different antiphospholipid (aPL) antibody profiles
    Pengo, V., Ruffatti, A., Tonello, M., Hoxha, A., Bison, E., Denas, G., Padayattil Jose, S., Zoppellaro, G., Bracco, A., Banzato, A. · 2015 · Thrombosis Research
  63. International Multicenter, Multiplatform Study to Validate Taipan Snake Venom Time as a Lupus Anticoagulant Screening Test with Ecarin Time as the Confirmatory Test: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
    Moore, Gary W., Jones, Paul O., Platton, Sean, Hussain, Nadia, White, Danielle, Thomas, Will, Rigano, Joseph, Pouplard, Claire, Gray, Elaine, Devreese, Katrien M.J. · 2021 · Journal of Thrombosis and Haemostasis
  64. Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters
    Andreina Manfredi, Marco Sebastiani, Valeria Carraro, Michele Iudici, Mario Bocci, Gentiana Vukatana, Roberto Gerli, Rossella De Angelis, Patrizia Del Medico, Emanuela Praino et al. · 2015 · Clinical Hemorheology and Microcirculation
  65. Reality Check on Antiphospholipid Antibodies in COVID‐19–Associated Coagulopathy
    Elena Gkrouzman, Medha Barbhaiya, Doruk Erkan, Michael D. Lockshin · 2020 · Arthritis & Rheumatology
  66. Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
    Marco Capecchi, Maria Abbattista, Alessandro Ciavarella, Mario Uhr, Cristina Novembrino, Ida Martinelli · 2022 · Journal of Clinical Medicine
  67. Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
    Lucas Jacobs, N. Wauters, Yahya Lablad, Johann Morelle, Maxime Taghavi · 2024 · Antibodies
  68. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome
    Markos Patsouras, Marina P. Sikara, E. Grika, Haralampos Μ. Moutsopoulos, Athanasios G. Tzioufas, Panayiotis G. Vlachoyiannopoulos · 2015 · Journal of Autoimmunity
  69. Thrombophilia: 2009 update
    Pat Foy, Stephan Moll · 2009 · Current Treatment Options in Cardiovascular Medicine
  70. Pregnancy Morbidity in Antiphospholipid Syndrome: What Is the Impact of Treatment?
    Guilherme Ramires de Jesús, Gustavo Rodrigues, Nilson Ramires de Jesús, Roger A. Levy · 2014 · Current Rheumatology Reports
  71. The impact of severe preeclampsia on maternal quality of life
    Christina Stern, Eva-Maria Trapp, Eva Mautner, Maria Deutsch, Uwe Lang, Mila Cervar-Zivkovic · 2013 · Quality of Life Research
  72. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future
    Ali A. Mehdi, Imad W. Uthman, Munther A. Khamashta · 2010 · European Journal of Clinical Investigation
  73. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus
    Julio Mayorga, D. Alpizar-Rodriguez, J Prieto-Padilla, Juanita Romero‐Díaz, Marı́a del Carmen Cravioto · 2015 · Lupus
  74. Aspirin adherence during high-risk pregnancies, a questionnaire study
    Carolien N. H. Abheiden, Alexandra Vera Ruth van Reuler, Wessel Willem Fuijkschot, Johanna I.P. de Vries, Abel Thijs, Marjon Alina de Boer · 2016 · Pregnancy Hypertension
  75. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies
    Małgorzata Maria Bała, Elżbieta Paszek, Wiktoria Leśniak, Dorota Włoch-Kopeć, Katarzyna Jasińska, Anetta Undas · 2018 · Cochrane Database of Systematic Reviews
  76. Factors associated with adverse pregnancy outcomes in women with antiphospholipid syndrome: A multicenter study
    Masashi Deguchi, Hideto Yamada, Mayumi Sugiura‐Ogasawara, Mamoru Morikawa, Daisuke Fujita, Akinori Miki, Shintaro Makino, Atsuko Murashima · 2017 · Journal of Reproductive Immunology
  77. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management
    Massimo Radin, Michelle Remião Ugolini Lopes, Savino Sciascia, DANIELI CASTRO OLIVEIRA DE ANDRADE · 2018 · Seminars in Arthritis and Rheumatism
  78. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements
    Polona Žigon, A Podovšovnik, Aleš Ambrožič, Matija Tomšič, Alojzija Hočevar, Nataša Gašperšič, Žiga Rotar, Sonja Praprotnik, Snežna Sodin Šemrl, Saša Čučnik · 2018 · Clinical Rheumatology
  79. The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants
    Michał Ząbczyk, Magdalena Kopytek, Joanna Natorska, Anetta Undas · 2019 · Clinical Chemistry and Laboratory Medicine (CCLM)
  80. Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients—a multicenter retrospective cohort
    Basma M. Medhat, Mervat Essam Behiry, Nesreen Sobhy, Yomna Mohamed Farag, Huda Marzouk, Noha S. Mostafa, Iman A. Khalifa, Marwa Elkhalifa, Basma M. Eissa, Eman Hassan · 2019 · Clinical Rheumatology
  81. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention
    Allison Bethanne Reiss, Benna Jacob, Saba Ahmed, Steven E. Carsons, Joshua R. DeLeon · 2021 · Inflammation
  82. Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
    Katrien M.J. Devreese, Stéphane Zuily, Pier Luigi Meroni · 2021 · Journal of Translational Autoimmunity
  83. Thrombophilia and Pregnancy
    Michael J. Kupferminc · 2005 · Current Pharmaceutical Design
  84. Lessons from the “Euro-Phospholipid” project
    Ricard Cervera · 2007 · Autoimmunity Reviews
  85. Laboratory diagnosis and management challenges in the antiphospholipid syndrome
    María Laura Bertolaccini, Munther A. Khamashta · 2006 · Lupus
  86. Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Vasileios Patriarcheas, Georgios Tsamos, Dimitra Vasdeki, Elias Alexandros Kotteas, Αναστάσιος Κόλλιας, Dimitris J. Nikas, Georgia D. Kaiafa, Evangelos P. Dimakakos · 2025 · Journal of Clinical Medicine
  87. Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
    Laura Cousins, Charis Pericleous, Munther A. Khamashta, María Laura Bertolaccini, Yiannis Ioannou, Ian Giles, Anisur Rahman · 2014 · Annals of the Rheumatic Diseases
  88. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants
    Devreese, Katrien M.J. · 2007 · Thrombosis Research
  89. Revisiting the Molecular Mechanism of Neurological Manifestations in Antiphospholipid Syndrome: Beyond Vascular Damage
    Miryam Carecchio, Roberto M. Cantello, Cristoforo Comi · 2014 · Journal of Immunology Research
  90. Amputation of Digits or Limbs in Patients with Antiphospholipid Syndrome
    Ronald A. Asherson, Ricard Cervera, Evandro Mendes Klumb, Ljudmila Stojanovich, Piercarlo Sarzi‐Puttini, Janet Yinh, Silvia Bucciarelli, Gerard Espinosa, Roger A. Levy, Yehuda Shoenfeld · 2008 · Seminars in Arthritis and Rheumatism
  91. Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus
    Evan S. Vista, Sherry R. Crowe, LF Thompson, Gillian M. Air, Robertson Jm, Joel M. Guthridge, James Ja · 2012 · Lupus
  92. The role of platelets in antiphospholipid syndrome
    Giulia Baroni, Alberto Banzato, Elisa Bison, Gentian Denas, Giacomo Zoppellaro, Vittorio Pengo · 2017 · Platelets
  93. Effects of Direct Oral Anticoagulants on Lupus Anticoagulant Assays in a Real-Life Setting
    Antovic, Aleksandra, Norberg, Eva-Marie, Berndtsson, Maria, Rasmuson, Agnes, Malmström, Rickard E., Skeppholm, Mika, Antovic, Jovan · 2017 · Thrombosis and Haemostasis
  94. microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome
    Lucas L. van den Hoogen, Marzia Rossato, Ana P. Lopes, Aridaman Pandit, Cornelis P. J. Bekker, Ruth D. E. Fritsch-Stork, Joël A. G. van Roon, Timothy R. D. J. Radstake · 2018 · Rheumatology
  95. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
    Savino Sciascia, Massimo Radin, Irene Cecchi, Elena Rubini, Anna Maria Scotta, Roberta Rolla, Barbara Montaruli, Patrizia Pergolini, Giulio Mengozzi, Emanuela Muccini et al. · 2019 · Frontiers in Immunology
  96. Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome
    Sarah Abramson Stoots, Lindsay Lief, Doruk Erkan · 2019 · Current Rheumatology Reports
  97. Sjögren Syndrome in Systemic Lupus Erythematosus: A Subset Characterized by a Systemic Inflammatory State
    Guillermo Ruacho, Marika Kvarnström, Agneta Zickert, Vilija Oke, Johan Rönnelid, Susanna Eketjäll, Kerstin Elvin, Iva Gunnarsson, Elisabet Svenungsson · 2019 · The Journal of Rheumatology
  98. Interstitial pneumonia with autoimmune features: A single center prospective follow-up study
    Marco Sebastiani, Giulia Cassone, Lisa De Pasquale, Stefania Cerri, Giovanni Della Casa, Caterina Vacchi, Fabrizio Luppi, Carlo Salvarani, Andreina Manfredi · 2019 · Autoimmunity Reviews
  99. Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One
    Pier Luigi Meroni, María Orietta Borghi · 2021 · Frontiers in Immunology
  100. Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus
    Ehtisham Akhter, Zakera Shums, Gary L. Norman, Walter L. Binder, Hong Fang, Michelle Petri · 2013 · The Journal of Rheumatology